These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1892521)

  • 1. Combined 5-fluorouracil and recombinant alpha-2a-interferon vs. 5-fluorouracil alone in metastatic colorectal carcinoma: a multicenter randomized study.
    Palmeri S; Gebbia V
    J Surg Oncol Suppl; 1991; 2():134-6. PubMed ID: 1892521
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II evaluation of recombinant alpha-2a-interferon and continuous infusion fluorouracil in previously untreated metastatic colorectal adenocarcinoma.
    Pazdur R; Ajani JA; Patt YZ; Gomez J; Bready B; Levin B
    Cancer; 1993 Feb; 71(4):1214-8. PubMed ID: 8435795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-fluorouracil and interferon-alpha-2a in advanced colorectal cancer. Results of two treatment schedules.
    John WJ; Neefe JR; Macdonald JS; Cantrell J; Smith M
    Cancer; 1993 Dec; 72(11):3191-5. PubMed ID: 8242541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Fluorouracil-interferon-alpha 2b adjuvant treatment of Dukes C colorectal cancer.
    Frasci G; Leone F; Monaco M; Cremone L; Sapio U; Faiella F; Espinosa A; Persico G
    Dis Colon Rectum; 1994 Jul; 37(7):643-50. PubMed ID: 8026229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modulation by recombinant alpha-2a-interfer on the activity and site of action of 5-fluorouracil on xenografted human colon cancer in nude mice: preliminary report].
    Yoshida K; Fujikawa T; Tanabe A; Sakurai K
    Nihon Geka Gakkai Zasshi; 1992 May; 93(5):559. PubMed ID: 1614401
    [No Abstract]   [Full Text] [Related]  

  • 6. Different dose regimens of 5-fluorouracil and interferon-alpha in patients with metastatic colorectal carcinoma.
    Ragnhammar P; Blomgren H; Edler D; Lundell G; Magnusson I; Sonnenfeld T
    Eur J Cancer; 1995; 31A(3):315-20. PubMed ID: 7786594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorouracil and recombinant interferon alfa-2a in advanced gastrointestinal neoplasms.
    Pazdur R
    Br J Haematol; 1991 Oct; 79 Suppl 1():56-9. PubMed ID: 1931711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced cytotoxicity of 5-fluorouracil combined with [6RS]leucovorin and recombinant human interferon-alpha 2a in colon carcinoma cells.
    Houghton JA; Adkins DA; Houghton PJ
    Adv Exp Med Biol; 1993; 339():133-42; discussion 165-7. PubMed ID: 8178712
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of recombinant human interferon-alpha 2a combined with 5-fluorouracil in patients with advanced colorectal carcinoma.
    Kim J; Zhi J; Satoh H; Koss-Twardy SG; Passe SM; Patel IH; Pazdur R
    Anticancer Drugs; 1998 Sep; 9(8):689-96. PubMed ID: 9823427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-alpha 2b and folinic acid. The "GISCAD" experience. Italian Group for the Study of Digestive Tract Cancer.
    Labianca R; Giaccon G; Barni S; Ambrosini G; Iirillo A; Fiorentini G; Duro M; Piazza E; Oliani C; Pancera G
    Eur J Cancer; 1994; 30A(11):1611-6. PubMed ID: 7833131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human interferon alpha-2a increases the antitumor activity of 5-fluorouracil on human colon carcinoma xenograft Co-4 without any change in 5-FU pharmacokinetics.
    Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Kuo TH; Saikawa Y; Teramoto T; Kitajima M
    Anticancer Res; 1995; 15(1):153-5. PubMed ID: 7733626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancer.
    Ravandi F; Rytting ME; Osmon C; Braud EL; Roach RW; Edwards K; Winn R; Abbruzzese JL; Pazdur R
    Anticancer Drugs; 1999 Jul; 10(6):519-24. PubMed ID: 10885898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to increase 5-fluorouracil activity with interferon-alpha 2a in the treatment of advanced colorectal cancer.
    Martoni A; Bidin L; Zamagni C; Cricca A; Pannuti F
    Eur J Cancer; 1995; 31A(1):127. PubMed ID: 7695965
    [No Abstract]   [Full Text] [Related]  

  • 14. Royal Marsden phase III trial of fluorouracil with or without interferon alfa-2b in advanced colorectal cancer.
    Hill M; Norman A; Cunningham D; Findlay M; Nicolson V; Hill A; Iveson A; Evans C; Joffe J; Nicolson M
    J Clin Oncol; 1995 Jun; 13(6):1297-302. PubMed ID: 7751874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of 5-fluorouracil and alpha-2b interferon in patients with hormone-refractory metastatic prostate cancer.
    Dreicer R; Forest PK; Williams RD
    Urology; 1994 Sep; 44(3):377-80. PubMed ID: 7521094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Fluorouracil plus interferon alpha-2a compared to 5-fluorouracil alone in the treatment of advanced colon carcinoma: a multicentric randomized study.
    Palmeri S; Meli M; Danova M; Bernardo G; Leonardi V; Dastoli G; Rausa L; Russo A; Filippelli G; Palmieri G; Russo A; Della Vittoria Scarpati M; Lo Russo V; Di Lauro L; Colucci G; Bruni G; Piazzi M; Gebbia N; Spada S
    J Cancer Res Clin Oncol; 1998; 124(3-4):191-8. PubMed ID: 9619746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of 5-fluorouracil-leucovorin activity by alpha2a-interferon in colon adenocarcinoma xenografts.
    Houghton JA; Cheshire PJ; Morton CL; Stewart CF
    Clin Cancer Res; 1995 Jan; 1(1):33-40. PubMed ID: 9815884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of metastatic colorectal carcinoma with lymphoblastoid interferon and 5-fluorouracil: data of a phase II study.
    Barzacchi MC; Nobile MT; Sanguineti O; Sertoli MR; Chiara S; Repetto L; Forno G; Lavarello A; Rosso R
    Anticancer Res; 1994; 14(5B):2147-9. PubMed ID: 7840514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma.
    Olencki T; Peereboom D; Wood L; Budd GT; Novick A; Finke J; McLain D; Elson P; Bukowski RM
    J Cancer Res Clin Oncol; 2001 May; 127(5):319-24. PubMed ID: 11355147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of 5-fluorouracil in colorectal cancer patients receiving interferon.
    Pittman K; Perren T; Ward U; Primrose J; Slevin M; Patel N; Selby P
    Ann Oncol; 1993 Jun; 4(6):515-6. PubMed ID: 8353094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.